Efficacy and safety of high ration HVWF/FVIII concentrate (VONCENTO (R)) for the treatment of bleeding epidodes in patients with WITH VON WILLEBRAND disease :s: the OPALE French experience - Université d'Angers Accéder directement au contenu
Article Dans Une Revue Haemophilia Année : 2022

Efficacy and safety of high ration HVWF/FVIII concentrate (VONCENTO (R)) for the treatment of bleeding epidodes in patients with WITH VON WILLEBRAND disease :s: the OPALE French experience

Dates et versions

hal-03629091 , version 1 (04-04-2022)

Identifiants

Citer

R. d'Oiron, L. Rugeri, A. Harroche, A. Fournel, A. Hassoun, et al.. Efficacy and safety of high ration HVWF/FVIII concentrate (VONCENTO (R)) for the treatment of bleeding epidodes in patients with WITH VON WILLEBRAND disease :s: the OPALE French experience. Haemophilia, 2022, 28 (S1), pp.107-108. ⟨10.1111/hae.14479⟩. ⟨hal-03629091⟩
33 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More